Annual EPS
-$0.57
+$0.95+62.50%
December 31, 2023
Summary
- As of February 12, 2025, XFOR annual earnings per share is -$0.57, with the most recent change of +$0.95 (+62.50%) on December 31, 2023.
- During the last 3 years, XFOR annual EPS has risen by +$2.52 (+81.55%).
- XFOR annual EPS is now at all-time high.
Performance
XFOR EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EPS
-$0.18
-$0.63-140.00%
September 30, 2024
Summary
- As of February 12, 2025, XFOR quarterly earnings per share is -$0.18, with the most recent change of -$0.63 (-140.00%) on September 30, 2024.
- Over the past year, XFOR quarterly EPS has dropped by -$0.63 (-140.00%).
- XFOR quarterly EPS is now -140.00% below its all-time high of $0.45, reached on June 30, 2024.
Performance
XFOR Quarterly EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EPS
-$0.08
-$0.17-188.89%
September 30, 2024
Summary
- As of February 12, 2025, XFOR TTM earnings per share is -$0.08, with the most recent change of -$0.17 (-188.89%) on September 30, 2024.
- Over the past year, XFOR TTM EPS has dropped by -$0.17 (-188.89%).
- XFOR TTM EPS is now -188.89% below its all-time high of $0.09, reached on June 30, 2024.
Performance
XFOR TTM EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EPS Formula
EPS = Net Income - Preferred Dividends
Shares Outstanding
Net Income - Preferred Dividends
Shares Outstanding
Shares Outstanding
XFOR EPS Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +62.5% | -140.0% | -188.9% |
| 3 y3 years | +81.5% | -140.0% | -188.9% |
| 5 y5 years | +99.3% | +85.3% | +99.2% |
XFOR EPS Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +85.7% | -140.0% | +85.5% | -188.9% | +98.0% |
| 5 y | 5-year | at high | +87.7% | -140.0% | +86.2% | -188.9% | +99.2% |
| alltime | all time | at high | +99.4% | -140.0% | +98.2% | -188.9% | +99.7% |
X4 Pharmaceuticals EPS History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$0.18(-140.0%) | -$0.08(-188.9%) |
| Jun 2024 | - | $0.45(-273.1%) | $0.09(-113.0%) |
| Mar 2024 | - | -$0.26(+188.9%) | -$0.69(+16.9%) |
| Dec 2023 | -$0.57(-62.5%) | -$0.09(+800.0%) | -$0.59(-25.3%) |
| Sep 2023 | - | -$0.01(-97.0%) | -$0.79(-24.0%) |
| Jun 2023 | - | -$0.33(+106.3%) | -$1.04(-20.6%) |
| Mar 2023 | - | -$0.16(-44.8%) | -$1.31(-29.9%) |
| Dec 2022 | -$1.52(-61.9%) | -$0.29(+11.5%) | -$1.87(-33.7%) |
| Sep 2022 | - | -$0.26(-56.7%) | -$2.82(-15.1%) |
| Jun 2022 | - | -$0.60(-16.7%) | -$3.32(-4.0%) |
| Mar 2022 | - | -$0.72(-41.9%) | -$3.46(-14.4%) |
| Dec 2021 | -$3.99(+29.1%) | -$1.24(+63.2%) | -$4.04(+8.9%) |
| Sep 2021 | - | -$0.76(+2.7%) | -$3.71(-2.9%) |
| Jun 2021 | - | -$0.74(-43.1%) | -$3.82(-0.5%) |
| Mar 2021 | - | -$1.30(+42.9%) | -$3.84(+23.9%) |
| Dec 2020 | -$3.09 | -$0.91(+4.6%) | -$3.10(+8.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | -$0.87(+14.5%) | -$2.85(-10.9%) |
| Jun 2020 | - | -$0.76(+35.7%) | -$3.20(-7.5%) |
| Mar 2020 | - | -$0.56(-15.2%) | -$3.46(-63.8%) |
| Dec 2019 | -$4.63(-94.2%) | -$0.66(-45.9%) | -$9.57(-4.3%) |
| Sep 2019 | - | -$1.22(+19.6%) | -$10.00(-25.0%) |
| Jun 2019 | - | -$1.02(-84.7%) | -$13.34(-23.4%) |
| Mar 2019 | - | -$6.67(+512.7%) | -$17.42(+14.7%) |
| Dec 2018 | -$79.15(-19.8%) | -$1.09(-76.1%) | -$15.19(-37.2%) |
| Sep 2018 | - | -$4.56(-10.6%) | -$24.18(-7.2%) |
| Jun 2018 | - | -$5.10(+14.9%) | -$26.06(-3.9%) |
| Mar 2018 | - | -$4.44(-56.0%) | -$27.12(-4.8%) |
| Dec 2017 | -$98.70(+298.2%) | -$10.08(+56.5%) | -$28.49(+18.0%) |
| Sep 2017 | - | -$6.44(+4.5%) | -$24.15(+36.4%) |
| Jun 2017 | - | -$6.16(+6.0%) | -$17.71(+53.3%) |
| Mar 2017 | - | -$5.81(+1.2%) | -$11.55(+101.2%) |
| Dec 2016 | -$24.78(+73.8%) | -$5.74 | -$5.74 |
| Dec 2015 | -$14.26 | - | - |
FAQ
- What is X4 Pharmaceuticals annual earnings per share?
- What is the all time high annual EPS for X4 Pharmaceuticals?
- What is X4 Pharmaceuticals annual EPS year-on-year change?
- What is X4 Pharmaceuticals quarterly earnings per share?
- What is the all time high quarterly EPS for X4 Pharmaceuticals?
- What is X4 Pharmaceuticals quarterly EPS year-on-year change?
- What is X4 Pharmaceuticals TTM earnings per share?
- What is the all time high TTM EPS for X4 Pharmaceuticals?
- What is X4 Pharmaceuticals TTM EPS year-on-year change?
What is X4 Pharmaceuticals annual earnings per share?
The current annual EPS of XFOR is -$0.57
What is the all time high annual EPS for X4 Pharmaceuticals?
X4 Pharmaceuticals all-time high annual earnings per share is -$0.57
What is X4 Pharmaceuticals annual EPS year-on-year change?
Over the past year, XFOR annual earnings per share has changed by +$0.95 (+62.50%)
What is X4 Pharmaceuticals quarterly earnings per share?
The current quarterly EPS of XFOR is -$0.18
What is the all time high quarterly EPS for X4 Pharmaceuticals?
X4 Pharmaceuticals all-time high quarterly earnings per share is $0.45
What is X4 Pharmaceuticals quarterly EPS year-on-year change?
Over the past year, XFOR quarterly earnings per share has changed by -$0.63 (-140.00%)
What is X4 Pharmaceuticals TTM earnings per share?
The current TTM EPS of XFOR is -$0.08
What is the all time high TTM EPS for X4 Pharmaceuticals?
X4 Pharmaceuticals all-time high TTM earnings per share is $0.09
What is X4 Pharmaceuticals TTM EPS year-on-year change?
Over the past year, XFOR TTM earnings per share has changed by -$0.17 (-188.89%)